Adalimumab Superior to Placebo Across Uveitis Idiopathic Etiologies
Patients experienced prolonged time to treatment failure, meeting primary endpoints in VISUAL I and II trials.
Read More
C3F8 Superior to SF6 and Air in Treatment of Vitreomacular Traction
Patients treated with C3F8 saw a superlative 84% release rate, according to study authors.
Misery Loves Company: How Suicidal Behavior Spreads in Army Units and Beyond
Soldiers in army units where suicide attempts occured in the past year were more likely to attempt suicide themselves.
Lilly's Lasmiditan Meets Primary, Secondary Endpoints in Phase 3 Trials for Migraine
A statistically significant proportion of patients were migraine-free 2 hours after taking lasmiditan versus placebo.
FDA Panel Warns Against Approval of Janssen's Sirukumab
The Arthritis Advisory Committee unanimously supported the drug’s efficacy data, but not it’s safety profile.
Valeant Announces US Launch of Brodalumab Injection for Plaque Psoriasis
The drug is being marketed as the cheapest injectable psoriasis treatment available in the US.
The Connected Clinician's Top 5 Stories of the Week - July 28
Everything the clinician needs to stay connected.
MAVIRET Earns Marketing Authorization in Europe for HCV Treatment
The drug achieved 97.5% cure rates in clinical trials.
Physician Roll Call: The Current State of American Health Care
Surgeons, cardiologists, pediatricians, endocrinologists and more share their thoughts on the uncertain health care climate in the US.
FYCOMPA Gets FDA Nod for Epilepsy Treatment
The drug has been approved in 55 countries and used to treat 100,000 patients.
Rexista Loses Approval Recommendation
Intellipharmaceutics plans further studies to prove Rexista’s worth as an abuse-deterrent painkiller.
Joint Committees Review Rexista, an Abuse-Deterrent Opioid Painkiller
Committees will discuss the drug's risk/benefit profile and whether it can safely deter abuse.
Human Trials Begin on First-Ever Preventative Vaccine for T1 Diabetes
Trials hold enormous potential, but could take a decade or more to complete.
FDA Rejects Lilly's Baricitinib
In a letter to the company, the FDA cited safety and dosage concerns as major factors in their decision.
Michael Grosso MD: Dealing with Vaccine Reluctance & Anti-Vaxxers
Michael Grosso, MD, discusses how a shift in societal norms has led parents to view doctors as consultants whose advice regarding their children can be freely rejected.
The Connected Clinician's Top 5 Stories of the Week
It's been a busy week in the world of public and private health care. Here's everything you need to know to stay connected.
AbbVie's HUMIRA Gets Positive Outlook from EMA
The drug, which has previously been approved to treat several other conditions, is now receiving EMA feedback for the treatment of uveitis in children.
Novartis Gets FDA Go-Ahead for Erenumab BLA
Erenumab reduced the number of migraine-affected days per month in phase 2 and 3 studies of more than 2600 patients.
FDA Approves First MRI Device for Neonatal Brain
Aspect Imaging's Embrace Neonatal MRI System is designed specifically for imaging of the neonatal head.
Merck Gets FDA's Approval for LUSDUNA Nexvue Pending Outcome of Sanofi Infringement Suit
Sanofi’s 2016 lawsuit invokes a 30 month stay on final FDA approval.
How to Determine When HIV Patients Should Switch ART Regimens
Switching ART regimens could mean the difference between poor health outcomes and effective viral suppression.
New Triple Combo Regimens Could Treat Underlying Cause of Cystic Fibrosis
Vertex Pharma’s new Phase 1 and 2 data could help patients with F508del/Min mutations – a severe and difficult-to-treat form of Cystic Fibrosis.
There Are Now More Than 100 Million Americans with Diabetes or Prediabetes
Disease rates have steadied, but the condition remains a major public health crisis.
FDA OK's Vosevi for Chronic Hepatitis C Treatment
The drug was granted priority review and breakthrough therapy status by the FDA.
CDC Issues $12 Million to Help 23 States Fight Opioid Epidemic
The agency plans to provide additional funding to further the cause later this summer.
FDA Accepts Application for Potential First Gene Therapy for Genetic Disease in US
If approved, LUXTURNA would also be the first pharmacological treatment for inherited retinal disease
HIV Discovery Could Lead to New Infection-Blocking Drugs
NIH researchers have successfully identified and blocked a previously undiscovered step in the HIV infection process.
56 Physicians Among Hundreds Charged in $1.3B Health Care Fraud Scandal
The Department of Justice is coordinating efforts with more than 1,000 state and federal agents in the largest health care fraud takedown in US history.
FDA Investigation of Lead-Testing Facility Uncovers Several Potential Federal Violations
The FDA is encouraging healthcare providers to retest patients tested for lead exposure with Magellan Diagnostics devices.
Children with Autism Inherit Their Unique Visual Attention Tendencies
Autistic children inherit behaviors that make them less likely to look at eye and mouth regions of the face.